Objectives: To quantify associations between antimicrobial use and acquired resistance in indicator Escherichia coli over a period of time which involved sector-wide antimicrobial use reductions in broilers and pigs (years 2004-14), veal calves (2007 -14) and dairy cattle (2005 -14). Prevalence estimates of resistance were predicted for a hypothetical further decrease in antimicrobial use.
Introduction
The use of antibiotics is the major driver for the emergence of bacterial resistance, which can be transmitted from food-producing animals to humans. 1 -8 During recent years, many efforts have been made in Europe for a more prudent veterinary use of antimicrobials, such as the EU-wide ban on the use of growth promoters in 2006, and the development of comprehensive antimicrobial use and resistance monitoring programmes. 9 -13 In the Netherlands, regulations for farmers and veterinarians have also changed considerably in recent years. 14, 15 In 2007, antimicrobial sales for food animals made the country one of the highest consumers of these products among the EU member states, 13, 16 and the government, animal sectors and veterinarians initiated concerted action to tackle this situation. In 2010, an ambitious policy defined mandatory targets for veterinary antimicrobial use, aiming at reductions of 50% by 2013 and 70% by 2015 compared with the index year 2009. The first target was easily achieved in 2013. 17 Additionally, from that year on, the use of third-and fourth-generation cephalosporins and fluoroquinolones was restricted by law for infections demonstrated by bacterial culture and susceptibility test results. 18 In recent years, resistance levels in Campylobacter spp. and commensal Escherichia coli in the main livestock sectors have decreased, which is interpreted as evidence of these measures having a positive impact. 19 The purpose of this study was to explore and quantify the association between use of antimicrobials in animals and resistance levels in commensal indicator E. coli over a period that saw a major reduction in antimicrobial use within the four major livestock production sectors (broilers, pigs, veal calves and dairy cattle) in the Netherlands. Moreover, we explored a potential future scenario by predicting resistance rates that would result from a further reduction in antimicrobial use.
Materials and methods

Antimicrobial use and resistance data
A more detailed description of the data used for this study can be found in the Supplementary data (available at JAC Online) along with additional references. 20 -24 Briefly, we retrieved the annual defined daily dosages per animal per year (DDDA/Y) reported by the Netherlands Veterinary Medicines Authority (SDa) for total use and specific antimicrobial classes until 2014 per animal sector. 17 Additionally, we used the results for resistance in E. coli communicated annually in the Monitoring Antimicrobial Resistance and Antibiotic Use in Animals in the Netherlands (MARAN) reports. 19 Consistent with the MARAN reports, the terms 'resistance' or 'resistant' in this work refer to non-WT isolates defined by epidemiological cut-off values (www. eucast.org). 19 MDR refers to isolates with non-WT susceptibility to three or more antimicrobial classes. 25 Years in which both antimicrobial use and resistance data were available were matched. Similarly, use per antimicrobial class was matched with susceptibility tests for corresponding antimicrobials. This resulted in eight used antimicrobial classes matching 10 antibiotics tested: usage of penicillins, tetracyclines, third-/fourth-generation cephalosporins, fluoroquinolones, quinolones and amphenicols matched with acquired resistance to ampicillin, tetracycline, cefotaxime, ciprofloxacin, nalidixic acid and chloramphenicol, respectively; aggregated information by the SDa on use of trimethoprim/sulphonamides was matched with both trimethoprim and sulfamethoxazole resistance, and use of aminoglycosides with resistance to both gentamicin and streptomycin.
Statistical analysis
Resistance patterns were assessed during the study period for the panel of nine antimicrobials excluding streptomycin, which was not tested every year. The same pattern evaluation was made for the period including streptomycin. Percentages of isolates resistant to each antimicrobial, among isolates exhibiting a certain number of resistance phenotypes (from 0, fully susceptible; to 9 or 10, pan-resistant to all agents), were calculated. We defined 1 2 [pan-susceptibility] as the proportion of isolates resistant to at least one of the antimicrobials (i.e. 1 2 proportion of isolates susceptible to all agents). Trends for annual antimicrobial use and for prevalence of resistance were plotted using smoothed lines passing through the point estimates, and changes between the years 2009 and 2014 (from the implementation of the antimicrobial policies) were described.
Logistic regression analysis for grouped data (number of resistant isolates over the total tested) was used to obtain ORs for an E. coli isolate to be resistant to each antimicrobial agent (or to any agent, represented by 1 -[pan-susceptibility]) per 1 U increase in total antimicrobial use (total DDDA/Y, which included also occasional use of first-/secondgeneration cephalosporins, combinations of antibiotics, macrolides/lincosamides, pleuromutilins and polymyxins) or 1 U increase in homologous use (i.e. DDDA/Y corresponding to the same antimicrobial class as the agent tested). Two multivariate random-effects generalized linear mixed models were fitted per animal sector. Models were adjusted for year and included a random intercept to account for the correlation between the different antimicrobial resistance phenotypes per year. The first model explored the associations between total antimicrobial use and resistance (agent-specific and 1 2 [pan-susceptibility]). The second model assessed the relationships between homologous antimicrobial use and corresponding agent resistance. For the latter, only classes with DDDA/Y. 0.5 in all years were modelled to obtain model convergence and reliable estimates. A categorical explanatory variable with the resistance types (agent-specific and 1 2 [pansusceptibility]) was included and its interaction with DDDA/Y was used to separate the different model outcomes. In veal calves, an extra variable was included in the model to adjust the OR estimates for the two different sampling frames used in this sector (i.e. until 2011 in farms and from 2012 at slaughterhouses). Model assumptions were checked with diagnostic plots. ORs and 95% CIs for the different associations were plotted. Finally, predicted E. coli resistance prevalence, related to a hypothetical total antimicrobial use reduction of 80% by 2016 from the index year 2009, were made per animal sector. Only the models with total antimicrobial use as a determinant were used to make the predictions. All models were fitted with PROC GLIMMIX in SAS software v. 9.2 (SAS Institute Inc., Cary, NC, USA). Sigma Plot software v. 12.5 (Systat Software Inc., San Jose, CA, USA) was used to create the graphs.
In a sensitivity analysis, we also explored the effect of a 1 year lag of antimicrobial use on resistance with the same models (e.g. relating antibiotic use in year 2013 with the resistance prevalence in 2014). These results were generally similar and are not presented.
Results
Resistance patterns
The percentages of antimicrobial resistance to each of the nine antimicrobials tested during 2004-14 (Tables S1 -S4) did not fundamentally differ from those including streptomycin (i.e. 10 agents) in the period 2007 -13 (Table 1) . Susceptibility to all antimicrobials was highest among isolates from dairy cattle (93%) while it was relatively low in veal calves and slaughter pigs (38% and 22%, respectively), and very low in broilers (12%) ( Table 1) . The highest level of multidrug resistance was observed in broilers (75% of isolates), followed by pigs (55%), veal calves (45%) and dairy cattle (4%) ( Table 1) . Patterns of resistance visualized by shaded cells were comparable between animals; resistance phenotypes to ampicillin, tetracycline, sulfamethoxazole, trimethoprim and streptomycin dominated among most of the multiresistant isolates, except for broilers, which showed an additional dominance of ciprofloxacin and nalidixic acid resistance (Table 1) .
A stratified analysis per period of time in all animal sectors (Tables S1 -S4) showed that susceptibility to all antimicrobials was higher in the last 4 years of the study when compared with the previous periods, and multidrug resistance was reduced. Nonetheless, resistance patterns did not fundamentally change over time; resistance to the most commonly used antimicrobials ( Figure 1 ) dominated in all linked phenotypes and cefotaxime resistance was related to isolates with the highest number of resistance phenotypes (Table 1) .
Long-term trends and changes in antimicrobial use and prevalence of resistance Trends in antimicrobial use and resistance by animal sector over the study period are displayed in Figure 1 . In broilers and slaughter Dorado-García et al. Table 2 . In broilers and slaughter pigs, relative decreases in use of the most commonly administered antimicrobials were the most dramatic (from 257% to 270% in broilers for total use and specific use of tetracyclines and quinolones; and from 254% to 263% in pigs for total and specific use of tetracyclines and trimethoprim/ sulphonamides). However, in broilers, the relative decrease in prevalence of resistance to these drugs was more limited (from 28% to 231%) than in pigs (from 222% to 243%). In the veal calf sector, a slightly more moderate decrease in use of the most common antimicrobials (from 240% to 244%) was paired with the most dramatic drop in prevalence of common resistance phenotypes (from 225% to 246%), potentially biased by the change in sampling strategy. In dairy cattle, antimicrobial use and resistance levels remained very low except for the unexplained sharp increase in 2009 that made the interpretation of relative changes difficult and unreliable. In all sectors, as a result of the implemented restriction policies, use of third-/fourthgeneration cephalosporins and fluoroquinolones was almost completely absent in 2014, and this was accompanied by noticeable changes in resistance when comparing 2009 with 2014 levels (284% reduction of cefotaxime resistance and 219% reduction of ciprofloxacin resistance in broilers, 286% and 2100% in pigs, 241% and 264% in veal calves, and 275% and 2100% in dairy cattle) ( Table 2) .
Associations between antimicrobial use and resistance
Dose -response antimicrobial use -resistance associations expressed as ORs and 95% CIs are shown in Figure 2 . The numerical outcomes of the models are presented in Table 3 . As a rule, the probability of E. coli resistant isolates was higher with increased use of antimicrobials (i.e. ORs.1). The different resistance phenotypes were more significantly associated (i.e. narrower CIs and ORs .1) with total antimicrobial use ( Figure 2a ) than with homologous use (Figure 2b ).
In broilers, the probability of an isolate being resistant to any of the antibiotics was from 1% to 5% higher per unit increase in total DDDA/Y; these associations were statistically significant or borderline significant (i.e. CIs for ORs ≥1), except for 1 2 [pansusceptibility], ampicillin and streptomycin resistance. Increased use in homologous antimicrobial classes was related to higher probabilities (e.g. fluoroquinolone use -ciprofloxacin resistance, OR ¼ 1.42). However, these homologous associations were often less significant (Figure 2a and b, Table 3 ).
In pigs, total antimicrobial use was positively related to resistance with higher probabilities than in broilers. One unit increase in DDDA/Y was associated with a 8% increased odds of total, tetracycline, ampicillin, trimethoprim and sulfamethoxazole resistance, and with a 30% -40% increased probability of ciprofloxacin and nalidixic acid resistance. In models with homologous use, ORs were never statistically significant (Figure 2a and b, Table 3 ).
In veal calves, the ORs for the relationships between total antimicrobial use and resistance were similar and statistically significant for most of the resistance phenotypes (ORs between 1.07 and 1.17). Statistical significance was lost in models accounting for the change in sampling strategy. Estimates from the models Antimicrobial use and resistant E. coli in livestock production 3611 JAC Table 3 ).
In dairy cattle, the antimicrobial use -resistance associations were the strongest (i.e. higher ORs), but they were not statistically significant (Figure 2a and b, Table 3) .
Occasionally, the models in the different species generated negative estimates which we deemed are likely implausible (i.e. increased antimicrobial use associated with reduced resistance). These estimates probably resulted from the intrinsic nature of our data (e.g. potential misclassifications) or from having fewer data points (e.g. for streptomycin, which was tested only during 2007-13, ORs,1 in broilers) (Figure 2a and b, Table 3 ).
Predicting resistance prevalence associated with an 80% reduction in antimicrobial use
Predicted resistance levels for 2016 in broilers remained similar to the observed ones in 2014; only ciprofloxacin and ampicillin resistance were expected to be reduced by 3%-4% but in some cases resistance was expected to increase (e.g. for tetracycline and cefotaxime) (Table 4 ). In pigs and veal calves, predictions were the most optimistic; 1 2 [pan-susceptibility] and resistance to the most commonly used antimicrobials were projected to decrease by 5%-9% in pigs and by 14% -28% in veal calves. In dairy cattle, 1 2 [pan-susceptibility] was projected to decrease by 3% (Table 4) .
Discussion
Our results suggest that a reduction in the use of antibiotics during the past 5 years in the Netherlands resulted in lowered E. coli resistance levels in some livestock industries. Generally positive and (borderline) statistically significant antimicrobial use -E. coli resistance relationships were derived, but the associations clearly differed between animal sectors. A further decrease in the use of these drugs was projected to have a clear impact, resulting in lower predicted levels of E. coli resistance, in the pig and veal calf industry. However, the relationships in broilers and dairy cattle were weaker and changes in E. coli resistance were projected to be minor. Multiresistant isolates were very common in all animal sectors and usage history and co-selection of phenotypes might explain to a large extent the observed patterns.
We focused on E. coli for various reasons. This bacterium is a widely used indicator of Gram-negative species incorporated in resistance surveillance systems, thus continuous data over several years were readily available. 19, 26 Moreover, E. coli is highly abundant in the intestinal tract of humans and animals and is an important vector for transmission of resistance genes between bacterial populations. 27 The use of DDDA/Y is a refined way of reporting antibiotic consumption, which has been recommended by the European Surveillance of Veterinary Antimicrobial Consumption (ESVAC). 13, 20 It enables the reporting of consumption by animal species and by antibiotic class, and it is considered as a better proxy of exposure since it accounts for the long-acting properties of some antimicrobials. Sampling in the monitoring programme was done mainly at the slaughterhouse level. Thus, resistant microorganisms should theoretically reflect antimicrobial use patterns and management practices as a whole during the life of these animals. However, it should be noted that antimicrobial consumption also occurs throughout the whole production chain in other animal groups (e.g. sows, boars, grandparent broilers) that are not directly represented by this sampling strategy. Sample size was sufficient to provide an estimate of the resistant E. coli population in each animal species of the entire country and, for representativeness, animals were sampled in all months of the year to account for possible seasonal effects. 19 Nonetheless, it should be noted that this sampling scheme is inherently insensitive to detecting resistance at the individual animal level and the resistance measure might not provide as sharp a picture of the situation at individual farms. 19, 28 This could be the reason for the drop in prevalence observed in veal calves after 2011 (Figure 1) , when the sampling scheme changed from farms to slaughterhouses. In the case of dairy cattle, the sharp increase in resistance observed in 2009 (Figure 1) was not fully explained but is probably attributable to the smaller sample taken in that year (n ¼ 136), which made it less representative. 19 Antimicrobial use differed quantitatively and qualitatively by animal sector and this appeared to drive the variation observed in resistance patterns (Table 1) . For instance, quinolone and fluoroquinolone resistance levels were exceptionally high in Table 3 ). The plotted estimates for veal calves originated from the model not accounting for change in sampling strategy. The dotted vertical reference line is used to assess significance (i.e. statistically significance at 95% CI if OR and CI are .1). AMP, ampicillin; TET, tetracycline; SMX, sulfamethoxazole; TMP, trimethoprim; CIP, ciprofloxacin; NAL, nalidixic acid; CHL, chloramphenicol; CTX, cefotaxime; STR, streptomycin (only tested from 2007 to 2013); GEN, gentamicin. 1 2 [pan-susceptibility] refers to isolates resistant to at least one of the agents of the susceptibility testing panel (i.e. 1 2 proportion of fully susceptible isolates). 
Continued
Antimicrobial use and resistant E. coli in livestock production 3615 JAC years, even with decreasing or no use of antibiotics, since resistance genes are often assembled in complex genetic vectors containing other resistance genes. 27, 29 This is the most likely explanation for the observed moderate to high levels of resistance to chloramphenicol and streptomycin, when use of these drugs was virtually zero (Figure 1 ). Resistance to more recently introduced drugs (around the 1990s), such as fluoroquinolones and third-generation cephalosporins, occurred less frequently and was often associated with multiresistance (Table 1) . Comparable findings have been described elsewhere. 29 This study suggests that curbing E. coli resistance rates in some livestock sectors is to a certain extent possible by reducing the use of antimicrobials. Specifically, cefotaxime and ciprofloxacin resistance was even more dramatically reduced in relative terms (Table 2) , which we deemed to be a product of the restriction in usage of third-/fourth-generation cephalosporins and fluoroquinolones. 30, 31 These findings suggest that, in E. coli, resistance to antibiotics with shorter usage history could be more rapidly reverted. Nonetheless, non-monotonic trends (e.g. reduction or suppression of antimicrobials related to both increased and decreased resistance over different time periods) have been described on several occasions for these drugs. 29 We found positive antimicrobial use -resistance doseresponse relationships that varied in magnitude and statistical significance by association and by animal sector (Figure 2 and Table 3 ). Similar associations have been demonstrated, especially in pigs and veal calves, but rarely based on longitudinal data and at the national level. 1, 3, 6, 32, 33 In a recent study, a direct antimicrobial use -resistance correlation at a supranational level was described, but findings were compromised by the cross-sectional nature of the associations and the lack of data per individual animal sectors. 2 We found the strongest usage -resistance relationships in slaughter pigs and veal calves, followed by the broilers (sectors with a relatively high use of antibiotics). In dairy cattle no statistically significant relationships were found. These observations might reflect important differences between animal industries in the structure, regimens of drug prescription and durations of the production cycle (broilers , veal calves , pigs , dairy cattle). In veal production, greater quantities of antimicrobials are applied cycle after cycle, and the frequency of animal replacement is lower than in other sectors. Pig production is an age-segregated system with continuous replacement, but with more stringent biosecurity conditions. Broilers are produced in a highly integrated system, where few companies control the supply of animals; they are also raised under highly confined conditions and receive more broad-spectrum drugs such as quinolones (i.e. more multiresistance). Administration of antimicrobials in dairy cows is usually more limited and on an individual basis, which could explain the lack of significant associations in our models. Despite all possible hypotheses, the reasons behind the low impact of the policy to reduce antimicrobial use in the broiler and dairy sectors requires further investigation.
We also unravelled differences between types of resistance ( Figure 2 and Table 3 ). Exposure-response slopes were often steeper for newer drugs (i.e. higher ORs for third-/fourth-generation cephalosporins in broilers and veal calves and higher ORs for fluoroquinolones in pigs and dairy cattle), but this needs cautious interpretation; baseline resistance levels were lower for these drugs, which might lead to larger estimates, although it also probably explained by a more rapidly reverted resistance to these antimicrobials. Moreover, total antimicrobial use was more significantly related to resistance phenotypes than homologous usage, showing the potential importance of co-selection of resistance. This means that if a reduction in resistance to a specific antimicrobial is intended, a reduction in all of the antimicrobials co-selecting for the same resistance is essential. Nonetheless, and regardless the significance, direct selection also played a role since some homologous associations had a greater effect.
A further decrease in antimicrobial use was predicted to result in more decreased resistance in the veal calf and pig sectors. In broilers, resistance trends seemed to level off (Table 4) ; a number of potential explanations exist. It is clear that use of antimicrobials contributes significantly to resistance emergence, but additional forces drive this process, such as movement of carrier animals between premises, transmission from the top of pyramidal production systems, keeping animals in close confinement, biosecurity and hygiene conditions, etc. 34 -37 Moreover, illegal use of ceftiofur was noticed up to March 2010 at broiler hatcheries; this use was not recorded and reported, but was deemed to increase levels of resistance to third-generation cephalosporins. 19 The data for this study came from publicly available reports. However, limiting factors existed in terms of interpretation and the level of detail. Our data were ecological, that is to say, antimicrobial use and resistance were evaluated at country level and not in corresponding and equal epidemiological units (e.g. farm level). This leads to potential misclassification of exposure In veal calves only the model not accounting for the change in sampling strategy was used to obtain the prediction.
Antimicrobial use and resistant E. coli in livestock production 3617 JAC to antimicrobials, which might be especially important in heterogeneous sectors such as veal calf production. Causality in this study strongly relied on the temporal and geographical link. An extra limitation arising from the level of aggregation of our data was the impossibility to account for other farm-level determinants of resistance and to adjust associations for these. 6, 38 Notwithstanding these constraints, we consider the data resolution to have been sufficient for the purpose of evaluating the nationwide programme. A methodological limitation was that our models were suited for well-established and long-standing relatively high levels of antimicrobial use and resistance; in order to obtain reliable estimates and model convergence, some homologous associations could not be studied when antimicrobials were used in very low quantities.
Conclusions
Recent Dutch policies reducing the total veterinary use of antimicrobials, and restricting the use of critically important antimicrobials, appear to have reduced (and are projected to further curb) E. coli resistance levels in veal calves and slaughter pigs. The impact on dairy cattle and broilers was, however, minor. Epidemiological evidence highlights the importance of a better understanding on the co-selection of resistance. Additional interventions need to be evaluated in future studies.
